Giovanni B.
- Country
- Italy
- Department
- Struttura di Medicina Trasfusionale
Research Overview
- Efficacy and Safety of Concizumab Prophylaxis in Reducing Bleeding Episodes in Adult and Adolescent Patients with Hemophilia A or B with Inhibitors
- Phase 3 Multicenter Randomized Study of Abelacimab vs. Apixaban on VTE Recurrence and Bleeding in Cancer-Associated Venous Thromboembolism
- A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B (PRESent-2)
Data & Insights
Has run more than one trial at 10 of 129 partner sites.
Specializations
Hemophilia Management
The investigator specializes in treating hemophilia A and B with inhibitors, exploring innovative prophylactic treatments for patients with severe conditions.
- Inhibitor Management in Hemophilia
- Prophylactic Treatment Approaches
- Bleeding Episode Prevention
The research focuses on evaluating novel therapeutic agents for improved bleeding prevention in hemophilia patients.
Advanced Hemophilia Therapeutics
Expertise in investigating subcutaneous treatment options for patients with severe and moderately severe hemophilia conditions.
- Novel Drug Development
- Subcutaneous Administration Methods
- Treatment Efficacy Assessment
Dedicated to advancing therapeutic options for both hemophilia A and B variants.
Thrombosis Research
Investigating treatments for cancer-associated venous thromboembolism (VTE), with a focus on preventing recurrence in high-risk patients.
- VTE Management in Cancer Patients
- Comparative Treatment Studies
- Bleeding Risk Assessment
Specializes in evaluating anticoagulation strategies for complex VTE cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.